Factors Related to the Beneficial Effects of Tolvaptan Treatment for Hepatic Ascites

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.47.17
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

Efficacy and Safety of a 14-Day Administration of Tolvaptan in the Treatment of Patients With Ascites in Hepatic Oedema

Journal of International Medical Research
BiochemistryMedicineCell Biology
2013English

Cases With Refractory Ascites and a Delayed Response to Tolvaptan

Internal Medicine
Internal MedicineMedicine
2016English

Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients With Refractory Ascites

Clinical Drug Investigation
MedicinePharmacology
2018English

TIPS for the Treatment of Refractory Ascites, Hepatorenal Syndrome and Hepatic Hydrothorax: A Critical Update

Gut
Gastroenterology
2010English

Intussusception: Factors Related to Treatment.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1990English

Use of a Pteridine Diuretic (Triamterene) in Treatment of Hepatic Ascites

BMJ
1962English

A Rational Approach to the Treatment of Ascites

Postgraduate Medical Journal
Medicine
1975English

Review of Tolvaptan in the Treatment of Hyponatremia

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Prediction of Risk Factors Related to the Development of Hepatic Dysfunction Following Open Heart Surgery

Critical Care
Critical CareIntensive Care Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy